Picture Berlin Partner Hotspot for Startups 650x80px

Document › Details

InflaRx N.V.. (11/21/18). "Press Release: InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results". Jena.

	Organisation	InflaRx N.V. (Nasdaq Global Select Market: IFRX)
	Group	InflaRx (Group)
	Organisation 2	MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
	Group	MorphoSys (Group)
	Product	IFX-1 (InflaRx)
	Product 2	drug development
	Person	Christ, Arnd (Immatics 202010– CFO before InflaRx + Proteros + MediGene + NovImmune + Probiodrug + Hoechst)
	Person 2	Holstein, Jens (BioNTech 202107– CFO before MorphoSys 201105–202012 CFO before Fresenius Kabi)

Original document
accessed by [iito] on 2018-11-24

Record changed: 2018-11-29

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for InflaRx (Group)

[1] Immatics N.V.. (9/29/20). "Press Release: Immatics Appoints Arnd Christ as Chief Financial Officer". Tübingen & Houston, TX....
[2] InflaRx N.V.. (9/17/20). "Press Release: InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer". Jena....
[3] InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena....
[4] InflaRx N.V.. (6/5/19). "Press Release: InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa". Jena....
[5] InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena....
[6] InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena....
[7] InflaRx N.V.. (1/3/19). "Press Release: InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management". Jena & New York, NY....
[8] InflaRx N.V.. (11/8/18). "Press Release: InflaRx Completes Enrollment in Phase IIb Clinical Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena....
[9] InflaRx N.V.. (9/21/18). "Press Release: InflaRx N.V. Announces Appointment of Jens Holstein to Board of Directors". Jena....
[10] InflaRx N.V.. (6/5/18). "Press Release: InflaRx Opens New Research Facility in Ann Arbor". Jena....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]